Davis Krista sold ANIP
March 9, 2026 · Form 4 insider transaction
Davis Krista sold 5,087 shares of ANI Pharmaceuticals, Inc. at $74.13 per share, a transaction worth $377.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,087
Price
$74.13
Total value
$377.1K
InsiderDavis Krista
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 9, 2026
Filing dateMarch 10, 2026
Shares owned after51,946
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025.; The shares were sold in multiple trades at prices ranging from $72.94 to $74.76. The price reported above reflects the weighted average sales price.